The CRO transition is unlikely to affect Vera's regulatory strategy or near-term stock performance. Monitor for any changes in regulatory submission timelines or pipeline updates in subsequent filings.
Price Chart
Executive Summary
Vera Therapeutics announced the transition of Chief Regulatory Officer William Turner to Special Advisor for Regulatory Affairs, effective August 3, 2026, with Nancy Bowman, M.D., Ph.D., succeeding him as CRO. This is a routine, orderly leadership change with a named successor, carrying no material operational or financial implications.
Key Facts
- William Turner steps down as Chief Regulatory Officer, transitions to Special Advisor for Regulatory Affairs effective August 3, 2026.
- Nancy Bowman, M.D., Ph.D., appointed as the new Chief Regulatory Officer, effective August 3, 2026.
- Orderly succession with both outgoing and incoming roles clearly defined.
Financial Impact
No financial figures disclosed in the filing.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-299165 |
| Document: 0001193125-26-299165-index-headers.html | 0001193125-26-299165 |
| Document: 0001193125-26-299165-index.html | 0001193125-26-299165 |
| Document: 0001193125-26-299165.txt | 0001193125-26-299165 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 8-K | $33.67 $34.00 | ▲ +0.98% | ▲ +0.16% | $30.13 (−10.53%) |
Aug 10, 2026 7w ago | 8-K | $30.29 $32.28 | ▲ +6.57% | ▲ +6.97% | $30.13 (−0.54%) |
Aug 10, 2026 7w ago | Press Release | $30.29 $32.28 | ▲ +6.57% | ▲ +6.97% | $30.13 (−0.54%) |
Jul 9, 2026 12w ago | 8-K | $42.45 $39.12 | ▼ −7.84% | ▼ −7.71% | $30.13 (−29.03%) |
Jul 7, 2026 12w ago | 8-K | $42.96 $43.13 | ▲ +0.40% | ▼ −0.16% | $30.13 (−29.88%) |
Jun 11, 2026 16w ago | Institutional Cluster | $33.65 $35.01 | ▲ +4.04% | ▲ +3.61% | $30.13 (−10.48%) |
Jun 2, 2026 17w ago | 8-K | $31.26 $31.81 | ▲ +1.76% | ▲ +4.72% | $30.13 (−3.63%) |
Jun 2, 2026 17w ago | Press Release | $31.26 $31.81 | ▲ +1.76% | ▲ +4.72% | $30.13 (−3.63%) |
May 7, 2026 21w ago | 8-K | $35.88 $39.15 | ▲ +9.11% | ▲ +7.61% | $30.13 (−16.04%) |
Feb 26, 2026 31w ago | 8-K | $42.35 $38.85 | ▼ −8.26% | ▼ −7.14% | $30.13 (−28.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access